Context Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 1,085,405 | 1.45% |
Hedge Funds | 7,776,296 | 10.4% |
General Public | 16,607,614 | 22.1% |
Institutions | 22,344,015 | 29.8% |
VC/PE Firms | 27,184,982 | 36.2% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 369.7%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
7,776,296 | US$11.4m | 4.81% | 0.59% | |||
7,419,355 | US$10.9m | 0% | 1.48% | |||
7,419,355 | US$10.9m | 0% | 0.31% | |||
6,934,982 | US$10.2m | -6.53% | 3.44% | |||
5,411,290 | US$8.0m | 4.84% | 2.95% | |||
3,744,961 | US$5.5m | -16.8% | no data | |||
2,440,330 | US$3.6m | 32.7% | 0.69% | |||
1,935,484 | US$2.8m | 0% | 0.19% | |||
1,853,988 | US$2.7m | 0% | no data | |||
1,757,524 | US$2.6m | -6.82% | 0.87% | |||
1,663,655 | US$2.4m | -14% | 0.01% | |||
1,360,682 | US$2.0m | 0% | 0.02% | |||
1,328,352 | US$2.0m | 0% | 0.89% | |||
1,321,153 | US$1.9m | -18.4% | 0.31% | |||
1,290,323 | US$1.9m | 0% | 1.89% | |||
979,891 | US$1.4m | 0% | no data | |||
848,970 | US$1.2m | -0.32% | no data | |||
575,899 | US$846.6k | -6.84% | no data | |||
373,835 | US$549.5k | -42.1% | 0.09% | |||
308,758 | US$453.9k | 5.11% | 0.04% | |||
260,000 | US$382.2k | 0% | 0.44% | |||
172,511 | US$253.6k | -1.14% | no data | |||
143,883 | US$211.5k | 0% | no data | |||
125,852 | US$185.0k | 0% | no data | |||
111,907 | US$164.5k | 21.5% | no data |